A 12-week Phase 3, Randomized, Double-blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of Once Monthly Subcutaneous Erenumab 70 mg in Adult Chronic Migraine Patients
收藏DataCite Commons2026-03-27 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/studies/PR00012893/isLanding
下载链接
链接失效反馈官方服务：
资源简介：
The purpose of this study was to evaluate the efficacy and safety of erenumab in patients with chronic migraine in Asian population.
提供机构：
Vivli
创建时间：
2026-03-27
